The Economic Revolution – Financial Weekly Newspaper Ahmedabad, Gujarat, India
IPOIPO Analysis By Dilip DavdaSME IPO ENGLISH

Apsis Aero NSE SME IPO Reivew

Courtesy:  https://www.chittorgarh.com/

Review By Dilip Davda on March, 2026

• The company is engaged in the field of precision engineering having prime focus on manufacturing components for aerospace, defence, healthcare industries.
• The company has marked growth in its top and bottom lines for the reported periods.
• The sudden surge in bottom lines from FY25 onwards raise eyebrows and concern over its sustainability going forward.
• Based on its recent financial data, the issue appears fully priced.
• Well-informed investors may park moderate funds for medium to long term.

ABOUT COMPANY:
Apsis Aerocom Ltd. (AAL) is engaged in the field of precision engineering, with primary focus on manufacture of components and allied services for the aerospace, defence and healthcare industries. Driven by modern manufacturing techniques, it provides engineering and precision machining services, offering end-to-end solutions ranging from design support to final product delivery. The Company manufactures products based on specific customer requirements and preferences. Each product is customized in accordance with the individual specifications provided by customers and is manufactured pursuant to confirmed orders. The Company supplies products directly to customers and does not sell its products through dealers, distributors, or other intermediaries.

Accordingly, the Company does not maintain a dealer or distributor network, and its sales are executed on a direct-to-customer basis. Its manufacturing processes have consistently demonstrated significant levels of dimensional accuracy over the last three fiscal years. The company maintains quality systems aligned with AS9100D and ISO 9001:2015 certifications, which are widely recognized standards in industries of operation.

AAL’s product offering caters to a specific niche segment of the aerospace, defence and healthcare industries. These include machined parts compliment the complex systems deployed in the aerospace, defence and healthcare industry. These products are manufactures as per client supplied designs and requirements. In India, the Company has established a market presence in Karnataka, Telangana, Maharashtra and Kerala, where it has developed ongoing business relationships with clients. The concentration in these states enables it to offer region-specific solutions while maintaining operational efficiency and responsiveness to customer requirements.

Internationally, the Company has strategically focused its efforts on select global markets, catering to certain customers based in the United States of America (USA), Spain, and Israel. These countries reflect the Company’s operational footprint in international markets, where it has provided services to different customers. However, contribution to its top lines from exports is minimal.

The Company aims to position itself as a trusted supplier for global OEMs by consistently delivering precision engineered components that adhere to international quality standards. It is committed to ensuring high precision, on-time delivery, and customer satisfaction, which constitute the core values guiding business. It also seeks to be a trusted and valued partner by providing efficient manufacturing solutions that support long-term customer success.

AAL offers end-to-end capabilities, from utilization of client provided drawings through CAD, material and process planning, CNC programming through CAM, machining, surface finishing, quality control, assembly to final inspection and product delivery. The company has lion share in its top line from southern regions. As of September 30, 2025, it had 105 employees on its payroll.

ISSUE DETAILS/ CAPITAL HISTORY:
The company is coming out with its maiden book building route IPO of 3252000 equity shares of Rs. 10 each to mobilize Rs. 35.77 cr. at the upper cap. The company has announced a price band of Rs. 104 – Rs. 110 per share. The minimum application to be made is for 2400 shares and in multiples of 1200 shares thereon, thereafter. The issue opens for subscription on March 11, 2026 and will close on March 13, 2026. The shares will be listed on NSE SME Emerge. The IPO constitute 26.98% of the post-IPO paid-up capital of the company. From the net proceeds of the equity issue, it will utilize Rs. 27.02 cr. for capex on purchase of machinery, and the rest for general corporate purposes.

The IPO is solely lead managed by Oneview Corporate Advisors Pvt. Ltd. (erstwhile known as Guiness Corporate Advisors Pvt. Ltd., and Integrated Registry Management Services Pvt. Ltd. is the registrar to the issue. Basan Equity Broking Ltd. is the market maker, as well as a syndicate member.

After issuing entire initial equity capital at par value, it issued bonus shares in the ratio of xx for xx in August 2025. The average cost of acquisition of shares by the promoters is Rs. 1.11 per share.

Post-IPO, company’s current paid-up equity capital of Rs. 8.80 cr. will stand enhanced to Rs. 12.05 cr. Based on the upper band of the IPO pricing, the company is looking for a market cap of Rs. 132.57 cr.

FINANCIAL PERFORMANCE:
On the financial performance front, for the last three fiscals, the company has (on a consolidated basis) posted total income/ net profit, of Rs. 10.41 cr. / Rs. 1.03 cr. (FY23), Rs. 16.88 cr. / Rs. 2.55 cr. (FY24), Rs. 20.57 cr. / Rs. 6.64 cr. (FY25). For H1 of FY26 ended on September 30, 2025, it earned a net profit of Rs. 3.12 cr. on a total income of Rs. 13.70 cr. The sustainability of such margins going forward is a major concern since it is operating in a highly competitive and fragmented segment. The segment is becoming overcrowded with rising competition.

For the last three fiscals, the company has reported an average EPS of Rs. 4.93 and an average RoNW of 65.53%. The issue is priced at a P/BV of 7.07 based on its NAV of Rs. 15.55 per share as of September 30, 2025, and at a P/BV of 2.68 based on its post-IPO NAV of Rs. 41.04 per share (at the upper cap).

If we attribute FY26 annualized super earnings to its post-IPO fully diluted paid-up equity capital, then the asking price is at a P/E of 21.24, and based on FY25 earnings, the P/E stands at 19.96. The issue appears fully priced based on its recent earnings. The company has posted PAT Margins of 9.89% (FY23), 15.14% (FY24), 32.39% (FY25), 22.88% (H1-FY26), and RoCE margins of 42.18%, 64.04%, 65.79%, 25.62%, respectively for referred periods.

DIVIDEND POLICY:
The company has not paid any dividends for the reported periods of the offer document. It has already adopted a dividend policy in March 2025, based on its financial performance and future prospects.

COMPARISON WITH LISTED PEERS:
As per the offer document, the company has shown Unimech Aerospace, as its listed peer. It is currently trading at a P/E of 68.3 (as of March 06, 2026). However, they are not truly comparable on an apple-to-apple basis. This compare is nothing but an eyewash.

MERCHANT BANKER’S TRACL RECORD:
This is the 6th mandate from Oneview Corporate (erstwhile Guiness Corporate) in the last three fiscals. Out of the last 5 listings, 1 at par, and the rest with premium ranging from 1.81% to 90.00% on the date of listing.

Conclusion / Investment Strategy
AAL is engaged in the field of precision engineering having prime focus on manufacturing components for aerospace, defence, healthcare industries. The company has marked growth in its top and bottom lines for the reported periods. The sudden surge in bottom lines from FY25 onwards raise eyebrows and concern over its sustainability going forward. Based on its recent financial data, the issue appears fully priced. Well-informed investors may park moderate funds for medium to long term.

Review By Dilip Davda on March, 2026

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detailed fundamental and financial analysis of companies coming up with IPOs helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: dilip_davda@rediffmail.com ).

Courtesy:  https://www.chittorgarh.com/

Related posts

ક્યૂએમએસ મેડિકલ એનએસઈ આરઆઈ સમીક્ષા

Compiled by Narendra Joshi

દેવ એક્સિલરેટર આઈપીઓ સમીક્ષા

Compiled by Narendra Joshi

એલજીટી બિઝનેસ બીએસઈ એસએમઈ આઈપીઓ સમિક્ષા

Compiled by Narendra Joshi